 (RR, 0.70; 95% CI, 0.69-0.82; P < .01). Longterm, however, dual antiplatelet therapy did not decrease
the risk of stroke recurrence (RR, 0.92; 95% CI, 0.83-1.03;
P ¼ .15), but it was associated with a signiﬁcantly higher
risk of hemorrh